6 research outputs found

    Rhinitis associated with asthma is distinct from rhinitis alone: TARIA‐MeDALL hypothesis

    Get PDF
    Asthma, rhinitis, and atopic dermatitis (AD) are interrelated clinical phenotypes that partly overlap in the human interactome. The concept of “one-airway-one-disease,” coined over 20 years ago, is a simplistic approach of the links between upper- and lower-airway allergic diseases. With new data, it is time to reassess the concept. This article reviews (i) the clinical observations that led to Allergic Rhinitis and its Impact on Asthma (ARIA), (ii) new insights into polysensitization and multimorbidity, (iii) advances in mHealth for novel phenotype definitions, (iv) confirmation in canonical epidemiologic studies, (v) genomic findings, (vi) treatment approaches, and (vii) novel concepts on the onset of rhinitis and multimorbidity. One recent concept, bringing together upper- and lower-airway allergic diseases with skin, gut, and neuropsychiatric multimorbidities, is the “Epithelial Barrier Hypothesis.” This review determined that the “one-airway-one-disease” concept does not always hold true and that several phenotypes of disease can be defined. These phenotypes include an extreme “allergic” (asthma) phenotype combining asthma, rhinitis, and conjunctivitis.info:eu-repo/semantics/publishedVersio

    ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice

    Get PDF
    Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.Peer reviewe

    Cabbage and fermented vegetables : From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

    Get PDF
    Large differences in COVID-19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage have been associated with low death rates in European countries. SARS-CoV-2 binds to its receptor, the angiotensin-converting enzyme 2 (ACE2). As a result of SARS-CoV-2 binding, ACE2 downregulation enhances the angiotensin II receptor type 1 (AT(1)R) axis associated with oxidative stress. This leads to insulin resistance as well as lung and endothelial damage, two severe outcomes of COVID-19. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is the most potent antioxidant in humans and can block in particular the AT(1)R axis. Cabbage contains precursors of sulforaphane, the most active natural activator of Nrf2. Fermented vegetables contain many lactobacilli, which are also potent Nrf2 activators. Three examples are: kimchi in Korea, westernized foods, and the slum paradox. It is proposed that fermented cabbage is a proof-of-concept of dietary manipulations that may enhance Nrf2-associated antioxidant effects, helpful in mitigating COVID-19 severity.Peer reviewe

    Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies

    Get PDF
    There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of rapamycin, PPAR gamma:Peroxisome proliferator-activated receptor, NF kappa B: Nuclear factor kappa B, ERK: Extracellular signal-regulated kinases and eIF2 alpha:Elongation initiation factor 2 alpha). They may as a result be important in mitigating the severity of COVID-19, acting through the endoplasmic reticulum stress or ACE-Angiotensin-II-AT(1)R axis (AT(1)R) pathway. Many Nrf2-interacting nutrients are also interacting with TRPA1 and/or TRPV1. Interestingly, geographical areas with very low COVID-19 mortality are those with the lowest prevalence of obesity (Sub-Saharan Africa and Asia). It is tempting to propose that Nrf2-interacting foods and nutrients can re-balance insulin resistance and have a significant effect on COVID-19 severity. It is therefore possible that the intake of these foods may restore an optimal natural balance for the Nrf2 pathway and may be of interest in the mitigation of COVID-19 severity

    Evaluation de la prise en charge intĂ©grĂ©e de l’otite moyenne chronique dans le systĂšme des soins de santĂ© primaires Ă  Kinshasa, RĂ©publique DĂ©mocratique du Congo: Assessment of integrated management of chronic otitis media in the primary health care system in Kinshasa, Democratic Republic of the Congo

    Get PDF
    Context and objective. Chronic Otitis Media (COM) is common with significant health and economic consequences. Health care workers play a key role in the management of this condition. This study aimed to assess the availability and adequacy of human and material resources for the management of COM in the primary health care system (PHC) in Kinshasa. Methods. In a crosssectional analytical study, four categories of human resources (community health relay, nurse, general practitioner, and medical specialist) providing PHC in Kinshasa were interviewed between July 2 and 21, 2020. Results. 218 health care providers participated. At the primary level, the availability of providers was observed, but their performance on basic care activities was poor among the Reco and IT interviewed. In multivariate logistic regression analysis, female gender, lack of training in PHC of the ear and lack of management materials were the factors independently associated with poor response among Reco while A1 and A2 education (awareness), lack of training in PHC of the ear andlack of equipment were the factors independently associated among IT. At the Reference GeneralHospital (RGH) level, the General Practitioners (GPs) interviewed showed a lack of a coherentand reliable referral system between the Health Center (HC) and the RGH as well as between theRGH and the specialist Center. At the tertiary level, 75% of the facilities had only medical treatment as the only treatment option due to lack of expertise (75%) and surgical equipment (87.5%) in surgical management according to the specialist doctors interviewed. Conclusion. Management of COM is not efficient in PHC in Kinshasa. Capacity building of health care providers on the management of COM is an urgent need in Kinshasa. Contexte & objectif. L’otite moyenne chronique (OMC) est une maladie trĂšs frĂ©quente aux consĂ©quences sanitaires et Ă©conomiques importantes. Le personnel soignant joue un rĂŽle primordial dans la prise en charge de cette pathologie. L’objectif de l’étude Ă©tait d’évaluer la disponibilitĂ© et l’adĂ©quation entre les ressources humaines et matĂ©rielles et les activitĂ©s de prise en charge de l’OMC. MĂ©thodes. Dans une Ă©tude transversale analytique, 4 catĂ©gories de ressources humaines (relais communautaire, infirmier titulaire, mĂ©decin gĂ©nĂ©raliste et mĂ©decin spĂ©cialiste) prestant dans le systĂšme des soins de santĂ© primaire (SSSP) de Kinshasa, ont Ă©tĂ© interviewĂ©s, entre les 2 et 21 juillet 2020. RĂ©sultats. 218 prestataires de soins ont participĂ©. Au niveau primaire, une disponibilitĂ© des prestataires a Ă©tĂ© objectivĂ©e, mais leur performance sur les activitĂ©s de prise en charge de base a Ă©tĂ© faible chez les interviewĂ©s. En analyse de rĂ©gression logistique multivariĂ©e, le sexe fĂ©minin, le manque de formation en SSP de l’oreille et l’absence d’équipement de PEC ont Ă©tĂ© les facteurs associĂ©s de maniĂšre indĂ©pendante Ă  une mauvaise rĂ©ponse chez les Reco tandis que chez les IT, il s’agissait des niveaux d’étude A1 et A2, le manque de formation en SSP de l’oreille et l’absence d’équipement. Au niveau de l’HGR, les mĂ©decins gĂ©nĂ©ralistes interviewĂ©s ont montrĂ© un manque de rĂ©fĂ©rence et de contre-rĂ©fĂ©rence entre le CS et l’HGR ainsi qu’entre l’HGR et le centre spĂ©cialisĂ©. Au niveau tertiaire, 75% des structures ne donnent que le traitement mĂ©dical faute d’expertise (75%) et de matĂ©riel de chirurgie (87,5%) dans la prise en charge chirurgicale selon les mĂ©decins spĂ©cialistes interviewĂ©s. Conclusion. La prise en charge intĂ©grĂ©e de l’OMC n’est pas optimale dans le SSSP Ă  Kinshasa. Un renforcement des capacitĂ©s des prestataires des soins sur la prise en charge de l’OMC est impĂ©rieux Ă  Kinshasa

    ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy" AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sante) \nPOLLAR (Impact of Air POLLution on Asthma and Rhinitis)\nGARD Demonstration project

    Get PDF
    Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.Peer reviewe
    corecore